Search research articles
Contact Us
Filters
Showing results (31-40 of 145) with videos related to
Page
of 15
Sort By:
Oncology Research and Treatment
|
August 5, 2021
Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience
Thomas Decker, Robert Seifert, Matthias Bichler, et al.
Seminars in Nuclear Medicine
|
November 7, 2022
Molecular Imaging of Lymphoma: Future Directions and Perspectives
Kelsey L Pomykala, Wolfgang P Fendler, Ophir Vermesh, et al.
Theranostics
|
August 15, 2019
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving <sup>177</sup>Lu-PSMA-617
Katharina Kessel, Robert Seifert, Michael Schäfers, et al.
Clinical Nuclear Medicine
|
June 16, 2026
Parathyroid Carcinoma Mimicking a Parathyroid Adenoma on [18F]F-Choline-PET With Occult Metastases
Carola M Bregenzer, Roman Trepp, Florian Dammann, et al.
Radiology
|
December 11, 2019
<sup>18</sup>F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks
Ludovic Sibille, Robert Seifert, Nemanja Avramovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 15, 2022
Is <sup>18</sup>F-FDG PET Needed to Assess <sup>177</sup>Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
Robert Seifert, Tugce Telli, Boris Hadaschik, et al.
PET Clinics
|
May 3, 2024
Prostate-specific Membrane Antigen: Diagnostics
Ian L Alberts, Robert Seifert, Rudolf A Werner, et al.
World Journal of Nuclear Medicine
|
December 23, 2020
Do fasting or high caloric drinks affect the physiological uptake of fluorine-18 prostate-specific membrane antigen-1007 in liver and bowel?
Kambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, et al.
Nuklearmedizin. Nuclear Medicine
|
August 29, 2024
Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands
Laya Rahbar Nikoukar, Robert Seifert, David Ventura, et al.
Cancers
|
August 7, 2021
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives
Konstantin Egon Seifert, Robert Seifert, Katharina Kessel, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 145) with videos related to
Sort By:
Page
of 15
Oncology Research and Treatment
|
August 5, 2021
Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience
Thomas Decker, Robert Seifert, Matthias Bichler, et al.
Seminars in Nuclear Medicine
|
November 7, 2022
Molecular Imaging of Lymphoma: Future Directions and Perspectives
Kelsey L Pomykala, Wolfgang P Fendler, Ophir Vermesh, et al.
Theranostics
|
August 15, 2019
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving <sup>177</sup>Lu-PSMA-617
Katharina Kessel, Robert Seifert, Michael Schäfers, et al.
Clinical Nuclear Medicine
|
June 16, 2026
Parathyroid Carcinoma Mimicking a Parathyroid Adenoma on [18F]F-Choline-PET With Occult Metastases
Carola M Bregenzer, Roman Trepp, Florian Dammann, et al.
Radiology
|
December 11, 2019
<sup>18</sup>F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks
Ludovic Sibille, Robert Seifert, Nemanja Avramovic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 15, 2022
Is <sup>18</sup>F-FDG PET Needed to Assess <sup>177</sup>Lu-PSMA Therapy Eligibility? A VISION-like, Single-Center Analysis
Robert Seifert, Tugce Telli, Boris Hadaschik, et al.
PET Clinics
|
May 3, 2024
Prostate-specific Membrane Antigen: Diagnostics
Ian L Alberts, Robert Seifert, Rudolf A Werner, et al.
World Journal of Nuclear Medicine
|
December 23, 2020
Do fasting or high caloric drinks affect the physiological uptake of fluorine-18 prostate-specific membrane antigen-1007 in liver and bowel?
Kambiz Rahbar, Ali Afshar-Oromieh, Robert Seifert, et al.
Nuklearmedizin. Nuclear Medicine
|
August 29, 2024
Prognostic value of pretherapeutic 68Ga-PSMA-11-PET based imaging parameters in mCRPC patients treated with PSMA radioligands
Laya Rahbar Nikoukar, Robert Seifert, David Ventura, et al.
Cancers
|
August 7, 2021
Lutetium-177 Labelled PSMA Targeted Therapy in Advanced Prostate Cancer: Current Status and Future Perspectives
Konstantin Egon Seifert, Robert Seifert, Katharina Kessel, et al.
Page
of 15